Table 1 Demographic and clinical characteristics of cervical cancer patients (n = 50)
Characteristic | n (%) |
|---|---|
Age (years) | |
≤ 40 | 8 (16) |
41–50 | 8 (16) |
51–60 | 21 (42) |
> 60 | 13 (26) |
Ethnicity | |
Black African | 44 (88) |
Indian/Asian | 3 (6) |
Coloured | 3 (6) |
Stage of cancer | |
I A | 1 (2) |
II A | 7 (14) |
II B | 25 (50) |
III A | 4 (8) |
III B | 13 (26) |
Comorbidities | |
None | 11 (22) |
HIV infection only | 20 (40) |
Hypertension only | 10 (20) |
Diabetes only | 2 (4) |
Diabetes and hypertension | 4 (8) |
HIV and hypertension | 2 (4) |
HIV and Epilepsy | 1 (2) |
Cisplatin Dosage | |
Mid-cycle (150 mg/m2) | 50 (100) |
One-month post-treatment follow up | |
150 mg/m2 | 8 (16) |
200 mg/m2 | 14 (28) |
250 mg/m2 | 10 (20) |
300 mg/m2 | 18 (36) |